Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Follow-Up Questions
Labcorp Holdings Inc (LH)의 PER은 얼마입니까?
Labcorp Holdings Inc의 PER은 31.1658입니다
Labcorp Holdings Inc의 CEO는 누구입니까?
Mr. Adam Schechter은 2013부터 회사에 합류한 Labcorp Holdings Inc의 Chairman of the Board입니다.
LH 주식의 가격 성능은 어떻습니까?
LH의 현재 가격은 $252.33이며, 전 거래일에 increased 0% 하였습니다.
Labcorp Holdings Inc의 주요 사업 주제나 업종은 무엇입니까?
Labcorp Holdings Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Labcorp Holdings Inc의 시가총액은 얼마입니까?
Labcorp Holdings Inc의 현재 시가총액은 $20.9B입니다
Labcorp Holdings Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 22명의 분석가가 Labcorp Holdings Inc에 대한 분석 평가를 실시했으며, 이는 10명의 강력한 매수, 14명의 매수, 5명의 보유, 0명의 매도, 그리고 10명의 강력한 매도를 포함합니다
